Allergen (AGN) Liability from EU Breast Implants is 'Fairly Limited - Cowen

December 19, 2018 11:16 AM EST Send to a Friend
Cowen analyst Ken Cacciatore weighed in on Allergen (NYSE: AGN) after the company suspended their sales for the textured breast ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login